Drug Discovery - The Rise of Molecular Glues: A New Class of Smart Cancer Drugs
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

High-throughput automation for smarter drug discoveryHigh-throughput automation for smarter drug discovery

CatSci’s partnership with Labman shows how intelligent solid-handling automation can reshape early-stage pharmaceutical development. By integrating the MultiDose platform, the team achieved a fourfold reduction in optimisation time, expanded screening capacity, and unlocked continuous overnight operation, empowering chemists to run hundreds of reactions with unprecedented speed and precision.

Unlock faster, data-driven discovery workflows
 
   The Rise of Molecular Glues: A New Class of Smart Cancer DrugsThe Rise of Molecular Glues: A New Class of Smart Cancer Drugs
 
Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision medicine and drug discovery.
 
   MIT AI Successfully Designs Protein Binders for Biology’s Toughest TargetsMIT AI Successfully Designs Protein Binders for Biology’s Toughest Targets
 
BoltzGen, an AI model from MIT, innovatively designs protein binders, combining structure prediction with flexible control for diverse biological applications.
 
   Laughing gas shows fast antidepressant effects in early clinical trialsLaughing gas shows fast antidepressant effects in early clinical trials
 
A systematic review and meta-analysis in eBioMedicine shows that nitrous oxide can rapidly reduce depressive symptoms within hours, particularly at higher doses, but effects are short-lived after single treatments. Repeated dosing appears to extend and strengthen antidepressant benefits, although the current evidence is based on small, early-phase trials with limited long-term safety data.
 
   Rentschler Biopharma and Coriolis Pharma Announce Strategic Collaboration for Integrated Biopharma SolutionsRentschler Biopharma and Coriolis Pharma Announce Strategic Collaboration for Integrated Biopharma Solutions
 
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Coriolis Pharma, a globally operating contract research and development organization (CRDO) and a leader in formulation research and development for biopharmaceuticals, today announced a strategic collaboration.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025